Per T Ljungman
机构:Karolinska University Hospital, Karolinska Institutet, European Society for Blood and Marrow Transplantation · ORCID:0000-0002-8281-3245
发表论文 805 篇 · 总被引 51669 次 · h-index 114
代表论文
- Consensus Definitions of Cytomegalovirus (CMV) Infection and Disease in Transplant Patients Including Resistant and Refractory CMV for Use in Clinical Trials: 2024 Update From the Transplant Associated Virus Infections Forum (2024 · Clinical Infectious Diseases · 被引 187)
- Vaccination of Adults With Cancer: ASCO Guideline (2024 · Journal of Clinical Oncology · 被引 123)
- Recommendations from the 10th European Conference on Infections in Leukaemia for the management of cytomegalovirus in patients after allogeneic haematopoietic cell transplantation and other T-cell-engaging therapies (2025 · The Lancet Infectious Diseases · 被引 84)
- Harmonizing definitions for hematopoietic recovery, graft rejection, graft failure, poor graft function, and donor chimerism in allogeneic hematopoietic cell transplantation: a report on behalf of the EBMT, ASTCT, CIBMTR, and APBMT (2024 · Bone Marrow Transplantation · 被引 77)
- Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis and neuromyelitis optica spectrum disorder — recommendations from ECTRIMS and the EBMT (2025 · Nature Reviews Neurology · 被引 60)
- Patient-Specific Measurable Residual Disease Markers Predict Outcome in Patients With Myelodysplastic Syndrome and Related Diseases After Hematopoietic Stem-Cell Transplantation (2024 · Journal of Clinical Oncology · 被引 32)